DCTH Delcath Systems, Inc.
Healthcare$10.83-1.72%ClosedMarket Cap: $373.9M
As of 2026-05-26
Valuation
P/E (TTM)
129.20
PEG
1.17
P/B
3.52
P/S
4.21
EV/EBITDA
1049.45
DCF Value
$-132.30
FCF Yield
5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.0%
Operating Margin
-1.8%
Net Margin
0.6%
ROE
0.5%
ROA
0.4%
ROIC
-0.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $25.0M | 85.1% | $-1.6M | $-1.1M | $— | — |
| Q4 null | $20.7M | 85.5% | $-2.2M | $-1.9M | $— | — |
| FY null | $85.2M | 86.2% | $660.0K | $2.7M | $— | — |
| Q3 null | $20.6M | 87.2% | $-388.0K | $830.0K | $— | — |
| Q2 null | $24.2M | 86.3% | $2.6M | $2.7M | $— | — |
| Q1 null | $19.8M | 85.6% | $642.0K | $1.1M | $— | — |
| Q4 null | $15.1M | 85.9% | $3.0M | $-3.4M | $— | — |
| FY null | $37.2M | 83.4% | $-12.4M | $-26.4M | $— | — |
| Q3 null | $11.2M | 85.4% | $-1.3M | $1.9M | $— | — |
| Q2 null | $7.8M | 80.4% | $-3.9M | $-13.7M | $— | — |
| Q1 null | $3.1M | 71.2% | $-10.3M | $-11.1M | $— | — |
| Q4 2023 | $539.0K | 68.3% | $-11.3M | $-11.1M | $-0.48 | — |